Efficacy and Safety of Neoadjuvant Targeted Therapy vs. Neoadjuvant Chemotherapy for Stage IIIA EGFR-Mutant Non-small Cell Lung Cancer: A Systematic Review and Meta-Analysis

Purpose: The role of targeted therapy in the neoadjuvant field of stage IIIA epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC) is still controversial. We sought to evaluate the efficacy and safety of neoadjuvant targeted therapy (NTT) with neoadjuvant chemo...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Dong, Jin, Zixian, Zhang, Jian, Xu, Congcong, Zhu, Kanghao, Ruan, Yuhang, Zhang, Bo, Chen, Baofu, Shen, Jianfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Surgery
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417411/
https://www.ncbi.nlm.nih.gov/pubmed/34490338
http://dx.doi.org/10.3389/fsurg.2021.715318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417411/
https://www.ncbi.nlm.nih.gov/pubmed/34490338
http://dx.doi.org/10.3389/fsurg.2021.715318

Ejemplares similares